Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic® into the Saudi, Jordanian and Iraqi Markets 1 min read Health and Family Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic® into the Saudi, Jordanian and Iraqi Markets AETOSWire February 12, 2024 into the Saudi, Jordanian and Iraqi Markets Amman, Jordan Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, has...Read More